EVOKE PHARMA, INC. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances

EVOKE PHARMA, INC. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances

EVOKE PHARMA, INC. reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances of $49.00 thousand for the 12-month period ending 2013-12-31, per its 10-K filed 2015-03-04.

Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation

us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues · last filed 2015-03-04

• EVOKE PHARMA, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, issuances for fiscal 2013 was $49.00K, a 102.06% increase from fiscal 2012.
• EVOKE PHARMA, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, issuances for fiscal 2012 was $24.25K.